ACTA1 and MELAS: Our previous data demonstrated that iPSCs derived from MELAS patients with a higher percentage of m.13513G>A mtDNA (≥84%) showed poor differentiation into αSMA-positive cells and TUBB3-positive neuronal cells with extended neurites.16